DNA Sequencing Market - Top Companies and Manufacturers

Companies Dominating the DNA Sequencing Landscape

The DNA sequencing market has witnessed rapid growth especially during and after the COVID-19 pandemic. The coronavirus mutations led to increased awareness and funding for the study of genomes and maintaining national depositories of genome data by many nations. The market is highly competitive, with numerous global and regional players seeking to innovate and solve the pain points of end users.

The key players in the DNA sequencing market are focused on expanding production capacities and investing in R&D to improve products making them more accurate and cost-effective. The market players are implementing strategies such as product launches, mergers & acquisitions, and strategic partnerships to enhance their market while retaining their position. Here are some key players dominating the global DNA sequencing market:

Illumina, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Myriad Genetics
PerkinElmer Inc.
Thermo Fisher Scientific
Hoffmann-La Roche Ltd.
Danaher Corporation
Eurofins Scientific
Bio-Rad Laboratories
Qiagen
BGI Group
Pacific Biosciences
Agilent Technologies

Browse Key Market Insights with Data Illustration:

DNA Sequencing Market Size & Share, Growth Trends 2037

In the News

In March 2024, Oxford Nanopore Technologies announced the launch of PromethION 2 with onboard computational capabilities. The device is expected to bring faster, accurate, and high-quality sequencing to research and academic labs.
In July 2023, MGI’s DNBSEQ-T7 received approval for clinical use in South Korea. DNBSEQ-T7 has a four-chip sequencing platform and is able to generate 7tb data per day and complete sequencing of 60 whole human genomes per day.
In August, 2021, Illumina Inc. acquired Grail. The acquisition is expected to accelerate the life-saving blood test by Grail that detects 50 different cancers before they are symptomatic.

Frequently Asked Questions (FAQ)

In 2024, the DNA sequencing industry is valued at USD 12.9 billion.

The market size for DNA sequencing is poised to cross USD 69.7 billion by the end of 2037. The market is expected to expand at a CAGR of 15.1% during the forecast period i.e., between 2025-2037. In 2024, the DNA sequencing market is valued at USD 12.9 billion.

The leading players in the market are Illumina, Inc., Myriad Genetics, Thermo Fisher Scientific, PerkinElmer Inc., Eurofins Scientific, Nippon Genetics and others.

The next generation sequencing (NGS) segment in technology will hold the largest market share for DNA sequencing during the forecast period i.e., 2025-2037. The segment is poised to grow at a rapid rate and register significant revenue CAGR owing to the low cost of NGS sequencing and the accuracy of results.

The North America market share is poised to be the largest with a revenue share of 51.5% by the end of 2037. The key drivers in North America are robust research infrastructure, high number of investments in research, and significant product launches.

DNA Sequencing Market - Top Companies and Manufacturers

Companies Dominating the DNA Sequencing Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the DNA sequencing industry?

What is the outlook for the DNA sequencing market?

Who are the major players dominating the DNA sequencing landscape?

Which segment will capture the significant market share for DNA sequencing by 2037?

Which region will provide more opportunities for the DNA sequencing business in the near future?